HealthQuill Genmab
The US health regulator has approved Pfizer’s drug to treat cervical cancer patients whose disease has progressed beyond the chemotherapy stage.
Drugs Health Pharma

Pfizer gets full US regulatory approval for cervical cancer drug

HQ Team April 30, 2024: The US health regulator has approved Pfizer’s drug to treat cervical cancer patients whose disease has progressed beyond.

Read More
AbbVie Inc and Danish drugmaker, Genmab, announced they have got FDA’s approval for a therapy to treat blood cancer in adults who have undergone at least two prior treatments.
Drugs Health Medical Pharma

AbbVie, Genmab get FDA approval for blood cancer therapy

HQ Team May 20, 2023: AbbVie Inc and Danish drugmaker, Genmab, announced they have got FDA’s approval for a therapy to treat blood.

Read More